Log in to save to my catalogue

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite,...

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3fd21ee1af543e1a133e6686028a69a

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study

About this item

Full title

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study

Publisher

London: British Medical Journal Publishing Group

Journal title

BMJ open, 2021-12, Vol.11 (12), p.e053604

Language

English

Formats

Publication information

Publisher

London: British Medical Journal Publishing Group

More information

Scope and Contents

Contents

ObjectiveTo examine associations between maternal use of cough medications containing dextromethorphan (DM) without guaifenesin (glyceryl guaiacolate (GG)) (‘DM alone’), GG without DM (‘GG alone’) or DM +GG and major birth defects in offspring.DesignPopulation-based case–control study.SettingThe multisite, US National Birth Defects Prevention Study...

Alternative Titles

Full title

Maternal use of cough medications during early pregnancy and selected birth defects: a US multisite, case–control study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f3fd21ee1af543e1a133e6686028a69a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3fd21ee1af543e1a133e6686028a69a

Other Identifiers

ISSN

2044-6055

E-ISSN

2044-6055

DOI

10.1136/bmjopen-2021-053604

How to access this item